If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
6.60    -0.25 (-3.65%)
Bid:
6.20
Ask:
7.00
Spread: 0.80 (12.903%)
Market Cap: £9.89m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Total Voting Rights

31 Dec 2025 07:00

RNS Number : 2069N
Ondo InsurTech PLC
31 December 2025
 

31 December 2025

 

 

Ondo InsurTech Plc

("Ondo" or "the Company")

 

Total Voting Rights and Shares in Issue update

 

Ondo InsurTech Plc (LSE: ONDO), a leading company in claims prevention technology for home insurers, is pleased to provide an update on its Shares in Issue and Total Voting Rights in accordance with the Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.

 

Exercise of Warrants

 

During the month of December 2025 1,251,507 new Ondo ordinary shares of 5 pence each ("Ordinary Shares") have been issued pursuant to warrant exercises and these shares were admitted to trading under the Company's blocklisting arrangements.

 

Placing, Subscription and Retail Offer

 

In total, the Placing, the Subscription, and the WRAP Retail Offer have raised gross proceeds of approximately £2.38 million for the Company, via the Placing and the Subscription of 9,211,200 Placing and Subscription Shares and the 305,928 WRAP Retail Offer Shares (together the "New Ordinary Shares"). The New Ordinary Shares were admitted to trading on 10 December 2025 and 11 December 2025.

 

 

Total Voting Rights

The Company's issued share capital as of 31 December 2025 comprises of 149,814,760 Ordinary Shares. The Company holds no shares in treasury.

 

Each Ordinary Share carries the right to one vote in relation to all circumstances at general meetings of the Company. The total number of voting rights in the Company is therefore 149,814,760.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries:

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Danial Ingram

Amber Higgs

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRMZMFZFGZGKZZ
Date   Source Headline
30th Sep 20257:00 amRNSTotal Voting Rights
22nd Sep 20254:08 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
4th Sep 20253:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20257:00 amRNSContract
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review
1st Aug 20258:56 amRNSTotal Voting Rights
30th Jul 20257:30 amRNSWarrant Exercise
30th Jul 20257:00 amRNSAnnual Financial Report
28th Jul 20251:44 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNS-RLeakBot Partnership with vipHomeLink in the U.S.
7th Jul 20251:00 pmRNSNotice of Results
1st Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 20257:30 amRNSTotal Voting Rights
30th Jun 20257:05 amRNSDirector/PDMR Shareholding
26th Jun 202512:30 pmRNSDirector/PDMR Shareholding
19th Jun 20254:01 pmRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSBear River Mutual to Pilot LeakBot in the US
12th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 202510:01 amRNSDirector/PDMR Shareholding
6th May 202512:34 pmRNSHolding(s) in Company
1st May 202510:00 amRNSDirector/PDMR Shareholding
1st May 202510:00 amRNSTotal Voting Rights
15th Apr 20255:06 pmRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
11th Apr 20257:00 amRNSThe Hanover to pilot LeakBot in the United States
2nd Apr 20257:00 amRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSTotal Voting Rights
11th Mar 20254:56 pmRNSDirector/PDMR Share Dealing
4th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNS-RMutual of Enumclaw to Expand LeakBot Program
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 20257:00 amRNS-RPURE expands LeakBot program
13th Feb 20257:00 amRNSTrading Update
13th Feb 20257:00 amRNSLiberty Mutual Insurance to Pilot LeakBot in US
5th Feb 202511:54 amRNSWarrant Exercise and Director/PDMR Shareholding
3rd Feb 20252:02 pmRNSDirector/PDMR Shareholding and TVR - Replacement
3rd Feb 20257:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
3rd Feb 20257:00 amRNSBlock listing Interim Review
31st Jan 20257:00 amRNS-RNorthumbrian Water to trial LeakBot
20th Jan 20253:40 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20245:58 pmRNSBlock Listing Application - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.